Monovisc 4ml Prefilled Syringe
Monovisc Prefilled Syringe
Monovisc 4ml is a single‑injection hyaluronic acid viscosupplement designed to relieve pain and improve mobility in adults with knee osteoarthritis. Supplied as a sterile, prefilled syringe, Monovisc delivers a high‑molecular‑weight sodium hyaluronate formulation for intra‑articular pain management and joint support.
Key Benefits
- Single‑injection convenience — one sterile 4ml prefilled syringe per treatment.
- Contains highly purified sodium hyaluronate for effective viscosupplementation of the knee joint.
- Helps reduce knee osteoarthritis pain and supports improved joint mobility.
- Local, intra‑articular treatment option for patients seeking alternatives to systemic pain medication.
- Produced by a trusted medical device manufacturer with consistent quality and safety standards.
Ingredients and Materials
Active ingredient: Sodium hyaluronate (hyaluronic acid) — sterile, highly purified, non‑animal sourced. Typical concentration: 22 mg/mL (88 mg total in 4 mL). Manufactured in a prefilled, single‑use syringe.
Other materials: Buffered sterile saline vehicle, glass/plastic syringe components, sterile needle (may be provided depending on pack). Packaged for single patient use by a licensed medical device manufacturer (Anika Therapeutics).
Keywords: Monovisc, hyaluronic acid, sodium hyaluronate, prefilled syringe, viscosupplementation, knee osteoarthritis.
How to Use
Monovisc is intended for intra‑articular injection into the knee joint and must be administered by a qualified healthcare professional. Follow these general steps:
- Assess the patient for suitability (no active joint infection, no known hypersensitivity).
- Use aseptic technique and prepare the injection site.
- Inject the full 4 mL dose into the intra‑articular space of the knee. Imaging guidance may be used when appropriate.
- Observe the patient briefly after injection for any immediate reactions. Single injection per treatment; do not re‑use the syringe.
Always follow local protocols and the product's official instructions for use.
Who It’s For
Monovisc is intended for adults with symptomatic knee osteoarthritis seeking local relief of pain and improved joint function. It may be appropriate for patients who:
- Have mild to moderate osteoarthritis of the knee.
- Prefer a local intra‑articular option over systemic medications (NSAIDs, opioids).
- Are looking for improved mobility and reduced knee pain between clinical follow‑ups or prior to surgical options.
Not indicated for use in children. A healthcare professional should evaluate suitability, especially in patients with bleeding disorders, active joint infection, or known hypersensitivity to any component.
Caution & Storage
Cautions: Do not use Monovisc if there is infection in or around the target joint, or if the patient has a known allergy to sodium hyaluronate or any component. Stop treatment if severe local or systemic allergic reactions occur. Use with caution in patients on anticoagulants or with bleeding disorders. Only for intra‑articular use. Single‑use only — discard any unused product.
Storage: Store at 2°C to 25°C (36°F to 77°F). Do not freeze. Keep in original packaging until use and protect from contamination. Dispose of syringe and needle following local medical waste regulations.
Keywords: storage, contraindications, adverse reactions, single‑use, intra‑articular injection.